In March 2026, WIRhE had the distinct honour to attend the International Maternal and Newborn Health Conference (IMNHC) in Nairobi, Kenya. In addition to attending the conference, we were selected to host an interactive stand during the ShareFair. The ShareFair held during IMNHC2026 provided an important platform to showcase our work, strengthen partnerships, and engage […]
We are deeply saddened by the passing of Professor Angela Okolo, a distinguished pediatrician and neonatologist, an active participant in WIRhE activities since its inception in 2019, and a valued member of our WIRhE Africa Board. Having Professor Okolo on our WIRhE Africa Board was a true honor; enabling us to work alongside her and […]
We are excited to share our 2025 Annual Report. We are grateful to our partners, donors, and funders for their collaboration and continued support to WIRhE and our goal of eradicating Rh disease worldwide. 2025 Global Overview Total number of individuals reached in-person in 2025: 2,804 individuals These numbers reflect only direct, in-person participants, not […]
An exclusive interview session with Alexandra M. Karim from the ministry of Health and also a laboratory scientist in charge of the Nothern Region Blood transfusion Center. Dr Sarah Luc, founder and director of international NGO Uman n Pikin Welbodi (UMPIWE) […]
In October 2025, the Plasma Protein Therapeutic Association (PPTA) held their Plasma Protein Forum. Our North America Chair, Steven Spitalnik was one of the session speakers. The session “Driving Awareness & Action for Anti-D” provided a thought-provoking discussion between experts, patients, and donors on the global challenges and opportunities shaping its future. The discussion focused […]
WIRhE gratefully acknowledges the International Society of Blood Transfusion (ISBT) for awarding their financial support of our upcoming event focused on Rh disease and maternal health (Event ID: 2025J-06). This support enables important dialogue among clinicians, researchers, advocates, and partners working to address Rh disease globally. The programme will include focused discussion on Rh immunoglobulin […]